` Comparison: BIOT vs DHR - Alpha Spread

BIOT
vs
DHR

Over the past 12 months, BIOT has significantly outperformed DHR, delivering a return of +45% compared to the DHR's 5% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
BIOT
DHR
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

BIOT Intrinsic Value
HIDDEN
Show
DHR Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Biotage AB
STO:BIOT
143.2 SEK
Danaher Corp
NYSE:DHR
195.93 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
BIOT, DHR

BIOT
DHR
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Biotage AB
Revenue
Danaher Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
BIOT, DHR

BIOT
DHR
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Biotage AB
STO:BIOT
Danaher Corp
NYSE:DHR
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BIOT
62.6%
DHR
59.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Biotage AB
Danaher Corp

Operating Margin

BIOT
16.7%
DHR
21.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Biotage AB
Danaher Corp

Net Margin

BIOT
13%
DHR
14.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Biotage AB
Danaher Corp

FCF Margin

BIOT
9.6%
DHR
21.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Biotage AB
Danaher Corp

ROE

BIOT
6.6%
DHR
7.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Biotage AB
Danaher Corp

ROA

BIOT
5.2%
DHR
4.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Biotage AB
Danaher Corp

ROIC

BIOT
6.6%
DHR
6.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Biotage AB
Danaher Corp

ROCE

BIOT
7.5%
DHR
7.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Biotage AB
Danaher Corp

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
BIOT, DHR

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BIOT, DHR

Performance Gap Between BIOT and DHR
HIDDEN
Show

Performance By Year
BIOT, DHR

Loading
BIOT
DHR
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare BIOT to other stocks
0KHE
PerkinElmer Inc
P
More expensive
vs BIOT
TMO
Thermo Fisher Scientific Inc
Cheaper
vs BIOT
207940
Samsung Biologics Co Ltd
More expensive
vs BIOT
LONN
Lonza Group AG
Cheaper
vs BIOT
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett